Inoperábilis nyelo{double acute}cso{double acute}tumor palliációja endoszkópos intubációval

Palotás András, Szentpáli Károly, Paszt Attila, Balogh Ádám, G. Lazar

Research output: Contribution to journalArticle

Abstract

Rationale: Access to expensive equipment and costly self-expanding metal endoprostheses is limited in some regions where unresectable esophageal cancer is not infrequent. The aim of this study was to review the long-term results of palliation of malignant esophageal obstruction using low-priced conventional plastic stents. Patients and methods: 103 patients with dysphagia due to inoperable esophageal cancer underwent esophageal intubation under endoscopic control alone, without general anesthesia, by the pulsion method. Stents mounted on their delivery device were inserted over an endoscopically placed guide wire. Results: Improvement in swallowing was seen in 100%. Dysphagia scores have improved from 3.64 ± 0.21 to 1.08 ± 0.17. Major early procedure-related morbidity was low (0.6%), with 1 intramural perforation and no transmural perforation at all. Minimal mucosal bleeding was seen with 48 cases (46.6%). Procedure-related mortality was 0%. Late procedure-related complications requiring further endoscopic procedures occurred in 13.5% (tube occlusion: 8.7%, tube dislocation: 4.8%). Our 7 day mortality was 0% and 5 patients had died within 30 days, usually from the disease itself. Those surviving the procedure (>7 days) had a mean survival of 209 days. Conclusion: Esophageal plastic stents can be accurately and safely placed under direct endoscopic control with lower costs. Therefore, endoscopic intubation remains a useful palliative treatment for patients with unresectable carcinoma of the esophagus.

Original languageHungarian
Pages (from-to)385-389
Number of pages5
JournalMagyar Onkologia
Volume47
Issue number4
Publication statusPublished - 2003

ASJC Scopus subject areas

  • Oncology

Cite this

Inoperábilis nyelo{double acute}cso{double acute}tumor palliációja endoszkópos intubációval. / András, Palotás; Károly, Szentpáli; Attila, Paszt; Ádám, Balogh; Lazar, G.

In: Magyar Onkologia, Vol. 47, No. 4, 2003, p. 385-389.

Research output: Contribution to journalArticle

András, P, Károly, S, Attila, P, Ádám, B & Lazar, G 2003, 'Inoperábilis nyelo{double acute}cso{double acute}tumor palliációja endoszkópos intubációval', Magyar Onkologia, vol. 47, no. 4, pp. 385-389.
András, Palotás ; Károly, Szentpáli ; Attila, Paszt ; Ádám, Balogh ; Lazar, G. / Inoperábilis nyelo{double acute}cso{double acute}tumor palliációja endoszkópos intubációval. In: Magyar Onkologia. 2003 ; Vol. 47, No. 4. pp. 385-389.
@article{919553e72b9347109d12f98733f0d8d4,
title = "Inoper{\'a}bilis nyelo{double acute}cso{double acute}tumor palli{\'a}ci{\'o}ja endoszk{\'o}pos intub{\'a}ci{\'o}val",
abstract = "Rationale: Access to expensive equipment and costly self-expanding metal endoprostheses is limited in some regions where unresectable esophageal cancer is not infrequent. The aim of this study was to review the long-term results of palliation of malignant esophageal obstruction using low-priced conventional plastic stents. Patients and methods: 103 patients with dysphagia due to inoperable esophageal cancer underwent esophageal intubation under endoscopic control alone, without general anesthesia, by the pulsion method. Stents mounted on their delivery device were inserted over an endoscopically placed guide wire. Results: Improvement in swallowing was seen in 100{\%}. Dysphagia scores have improved from 3.64 ± 0.21 to 1.08 ± 0.17. Major early procedure-related morbidity was low (0.6{\%}), with 1 intramural perforation and no transmural perforation at all. Minimal mucosal bleeding was seen with 48 cases (46.6{\%}). Procedure-related mortality was 0{\%}. Late procedure-related complications requiring further endoscopic procedures occurred in 13.5{\%} (tube occlusion: 8.7{\%}, tube dislocation: 4.8{\%}). Our 7 day mortality was 0{\%} and 5 patients had died within 30 days, usually from the disease itself. Those surviving the procedure (>7 days) had a mean survival of 209 days. Conclusion: Esophageal plastic stents can be accurately and safely placed under direct endoscopic control with lower costs. Therefore, endoscopic intubation remains a useful palliative treatment for patients with unresectable carcinoma of the esophagus.",
author = "Palot{\'a}s Andr{\'a}s and Szentp{\'a}li K{\'a}roly and Paszt Attila and Balogh {\'A}d{\'a}m and G. Lazar",
year = "2003",
language = "Hungarian",
volume = "47",
pages = "385--389",
journal = "Magyar Onkologia",
issn = "0025-0244",
publisher = "Akademiai Kiado",
number = "4",

}

TY - JOUR

T1 - Inoperábilis nyelo{double acute}cso{double acute}tumor palliációja endoszkópos intubációval

AU - András, Palotás

AU - Károly, Szentpáli

AU - Attila, Paszt

AU - Ádám, Balogh

AU - Lazar, G.

PY - 2003

Y1 - 2003

N2 - Rationale: Access to expensive equipment and costly self-expanding metal endoprostheses is limited in some regions where unresectable esophageal cancer is not infrequent. The aim of this study was to review the long-term results of palliation of malignant esophageal obstruction using low-priced conventional plastic stents. Patients and methods: 103 patients with dysphagia due to inoperable esophageal cancer underwent esophageal intubation under endoscopic control alone, without general anesthesia, by the pulsion method. Stents mounted on their delivery device were inserted over an endoscopically placed guide wire. Results: Improvement in swallowing was seen in 100%. Dysphagia scores have improved from 3.64 ± 0.21 to 1.08 ± 0.17. Major early procedure-related morbidity was low (0.6%), with 1 intramural perforation and no transmural perforation at all. Minimal mucosal bleeding was seen with 48 cases (46.6%). Procedure-related mortality was 0%. Late procedure-related complications requiring further endoscopic procedures occurred in 13.5% (tube occlusion: 8.7%, tube dislocation: 4.8%). Our 7 day mortality was 0% and 5 patients had died within 30 days, usually from the disease itself. Those surviving the procedure (>7 days) had a mean survival of 209 days. Conclusion: Esophageal plastic stents can be accurately and safely placed under direct endoscopic control with lower costs. Therefore, endoscopic intubation remains a useful palliative treatment for patients with unresectable carcinoma of the esophagus.

AB - Rationale: Access to expensive equipment and costly self-expanding metal endoprostheses is limited in some regions where unresectable esophageal cancer is not infrequent. The aim of this study was to review the long-term results of palliation of malignant esophageal obstruction using low-priced conventional plastic stents. Patients and methods: 103 patients with dysphagia due to inoperable esophageal cancer underwent esophageal intubation under endoscopic control alone, without general anesthesia, by the pulsion method. Stents mounted on their delivery device were inserted over an endoscopically placed guide wire. Results: Improvement in swallowing was seen in 100%. Dysphagia scores have improved from 3.64 ± 0.21 to 1.08 ± 0.17. Major early procedure-related morbidity was low (0.6%), with 1 intramural perforation and no transmural perforation at all. Minimal mucosal bleeding was seen with 48 cases (46.6%). Procedure-related mortality was 0%. Late procedure-related complications requiring further endoscopic procedures occurred in 13.5% (tube occlusion: 8.7%, tube dislocation: 4.8%). Our 7 day mortality was 0% and 5 patients had died within 30 days, usually from the disease itself. Those surviving the procedure (>7 days) had a mean survival of 209 days. Conclusion: Esophageal plastic stents can be accurately and safely placed under direct endoscopic control with lower costs. Therefore, endoscopic intubation remains a useful palliative treatment for patients with unresectable carcinoma of the esophagus.

UR - http://www.scopus.com/inward/record.url?scp=84874958613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874958613&partnerID=8YFLogxK

M3 - Article

C2 - 14716435

AN - SCOPUS:84874958613

VL - 47

SP - 385

EP - 389

JO - Magyar Onkologia

JF - Magyar Onkologia

SN - 0025-0244

IS - 4

ER -